Immunologic rebound after cessation of long-term chemotherapy in acute leukemia.

Suppr

超能文献

作者信息

Borella L, Green A A, Webster R G

出版信息

Blood. 1972 Jul;40(1):42-51.

PMID:4624721

Abstract

摘要

相似文献

Immunologic rebound after cessation of long-term chemotherapy in acute leukemia.

Blood. 1972 Jul;40(1):42-51.

Sequestration of PHA-responsive cells (T-lymphocytes) in the bone marrow of leukemic children undergoing long-term immunosuppressive therapy.

J Immunol. 1972 Nov;109(5):927-32.

Paraproteinemia in a child with leukemia.

Blood. 1970 Feb;35(2):213-21.

Immunoglobulins in acute leukemia in children.

J Pediatr. 1974 Dec;85(6):788-91. doi: 10.1016/s0022-3476(74)80341-0.

Acute lymphoblastic leukaemia treated with a combination of prednisone, vincristine, and rubidomycin. Value of pathogen-free rooms.

Lancet. 1967 Aug 19;2(7512):380-2. doi: 10.1016/s0140-6736(67)92004-1.

Factors that influence haematological remission duration in acute lymphocytic leukaemia.

Br J Haematol. 1976 Apr;32(4):465-72. doi: 10.1111/j.1365-2141.1976.tb00950.x.

Clinical and immunological recovery of children with acute lymphocytic leukemia admitted to "total therapy" studies.

Recent Results Cancer Res. 1973;43:145-50. doi: 10.1007/978-3-642-80776-3_24.

Phytohaemagglutinin stimulation of peripheral lymphocytes in children with acute lymphoblastic leukaemia during remission.

Scand J Haematol. 1972;9(1):36-42. doi: 10.1111/j.1600-0609.1972.tb00911.x.

Urticaria pigmentosa and acute lymphoblastic leukemia.

Arch Dermatol. 1973 Feb;107(2):283-4.

Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia.

N Engl J Med. 1971 Nov 25;285(22):1211-6. doi: 10.1056/NEJM197111252852201.

引用本文的文献

Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells.

Blood Adv. 2021 Apr 13;5(7):1862-1875. doi: 10.1182/bloodadvances.2020003300.

Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia.

Biol Blood Marrow Transplant. 2012 Jun;18(6):930-6. doi: 10.1016/j.bbmt.2011.11.015. Epub 2011 Nov 20.

Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages.

Immunology. 2011 Feb;132(2):226-39. doi: 10.1111/j.1365-2567.2010.03357.x. Epub 2010 Oct 13.

Deficient innate immunity, thymopoiesis, and gene expression response to radiation in survivors of childhood acute lymphoblastic leukemia.

Cancer Epidemiol. 2010 Jun;34(3):303-8. doi: 10.1016/j.canep.2010.03.008. Epub 2010 Apr 22.

The study of minimal residual disease in acute lymphoblastic leukaemia.

Clin Mol Pathol. 1995 Apr;48(2):M65-73. doi: 10.1136/mp.48.2.m65.

Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (ALL) of childhood.

Eur J Pediatr. 1982 Oct;139(2):113-7. doi: 10.1007/BF00441492.

Better results in childhood acute leukemia.

Br Med J. 1973 Jun 16;2(5867):624-5. doi: 10.1136/bmj.2.5867.624.

Blood and neoplastic diseases. Acute lymphoblastic leukaemia.

Br Med J. 1974 Nov 2;4(5939):282-4. doi: 10.1136/bmj.4.5939.282.

Current issues in the management of children with acute lymphocytic leukaemia.

Postgrad Med J. 1985 Feb;61(712):93-102. doi: 10.1136/pgmj.61.712.93.

Circulating thymic hormone activity in young cancer patients.

Clin Exp Immunol. 1986 Oct;66(1):173-80.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验